Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Celea Therapeutics, Inc. is seeking an experienced, strategic, and hands-on Associate Director/Director, Analytical Steward, CMC to serve as the end-to-end technical owner for analytical activities across the product lifecycle.
Based in Boston, this hybrid role drives phase-appropriate development, regulatory submissions, and lifecycle management for drug substances and products. You will lead analytical strategy, oversee CMOs/CDMOs, and ensure inspection readiness while collaborating with
About Celea Therapeutics
Celea Therapeutics is dedicated to advancing transformative treatments for people with serious respiratory diseases. Drawn from the Latin word for “sky,” our name reflects our mission to rise above the status quo and deliver therapies that change lives. Our lead program, deupirfenidone (LYT-100), is currently in Phase 3 clinical development with active candidate enrollment, representing a potential new standard of care for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.
Rising above the status quo takes a team as strong as its science, and we hire and work by five values: accountability — owning outcomes and acting like owners; transparency — talking straight and building trust; collaboration — achieving together what no one could alone; innovation — challenging accepted ideas and taking smart risks; and passion — bringing energy and heart to the mission.
Position Overview
As we prepare for our next stage of growth and clinical advancement, Celea is seeking an experienced, strategic, and hands-on Associate Director/Director, Analytical Stewart, CMC to serve as the end-to-end technical owner for analytical activities across the product lifecycle. Reporting to the Senior Vice President, CMC, this role provides strategic, scientific, and operational leadership for analytical development activities supporting late-stage clinical, registration, and commercial small molecule products. Analytical activities include phase-appropriate analytical method development, qualification, validation, transfer, and lifecycle management for regulatory starting materials, intermediates, drug substance, and drug product. The role is accountable for analytical control strategies, specifications, stability programs, reference standards, regulatory submissions, inspection readiness, and oversight of all analytical activities performed at CMOs, CDMOs, CROs, and contract testing laboratories.
This position is based in Boston, Hybrid with 3 days/onsite.
Key Responsibilities
Qualifications
Required
Preferred
Why Join Celea Therapeutics
Compensation
Transparency is one of our values, and that includes how we pay. The anticipated salary range for the Associate Director level is $190,000 – $205,000 , plus bonus and equity; for the Director level the range is$220,000 - $235,000 plus bonus and equity. Where an offer lands within the range reflects the candidate’s experience, skills, and internal equity — and we welcome open conversations about compensation from the first call, so there are no surprises at the offer stage.
Actual compensation will be determined based on experience, qualifications, and location. In addition to base pay, this role is eligible for bonus and equity compensation.
Base Pay Information
$190,000 - $235,000 USD
Our Commitment
Celea Therapeutics is an equal opportunity employer. We evaluate every candidate against the requirements of the role using a structured, evidence-based process, and we make employment decisions without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other legally protected characteristic.
For more information, visit www.celeatx.com or connect with us on Twitter @celeatx.